Loading viewer...
investor_presentation
Format: PDF investor_presentation
Avidity Biosciences presents its RNA therapeutic delivery platform and development strategy. The company is advancing multiple programs based on its proprietary AOC (Antibody Oligonucleotide Conjugate) platform, targeting RNA-based diseases with preclinical and early-stage clinical candidates.
Avidity Biosciences 2021 Corporate Presentation
investor_presentationinvestor_presentation
47 Pages
investor_presentation
34 Pages
UBS